Groupe la Francaise lowered its position in shares of Xylem Inc. (NYSE:XYL - Free Report) by 19.2% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 64,909 shares of the industrial products company's stock after selling 15,386 shares during the quarter. Groupe la Francaise's holdings in Xylem were worth $7,897,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Samjo Management LLC increased its stake in Xylem by 2.1% during the 1st quarter. Samjo Management LLC now owns 20,665 shares of the industrial products company's stock worth $2,469,000 after buying an additional 425 shares in the last quarter. Sax Wealth Advisors LLC purchased a new stake in Xylem during the 1st quarter worth approximately $575,000. Kestra Advisory Services LLC increased its stake in Xylem by 1.9% during the 1st quarter. Kestra Advisory Services LLC now owns 11,560 shares of the industrial products company's stock worth $1,381,000 after buying an additional 214 shares in the last quarter. Gitterman Wealth Management LLC increased its stake in Xylem by 9.2% during the 1st quarter. Gitterman Wealth Management LLC now owns 5,828 shares of the industrial products company's stock worth $696,000 after buying an additional 491 shares in the last quarter. Finally, RPG Investment Advisory LLC increased its stake in Xylem by 101.0% during the 1st quarter. RPG Investment Advisory LLC now owns 265,554 shares of the industrial products company's stock worth $31,723,000 after buying an additional 133,411 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.
Xylem Stock Down 0.7%
XYL stock traded down $0.9850 during trading on Monday, reaching $142.7550. The stock had a trading volume of 897,193 shares, compared to its average volume of 1,243,124. Xylem Inc. has a 1-year low of $100.47 and a 1-year high of $145.33. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. The company has a market capitalization of $34.75 billion, a P/E ratio of 37.08, a PEG ratio of 2.49 and a beta of 1.11. The firm has a fifty day moving average price of $134.57 and a 200 day moving average price of $126.47.
Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The business had revenue of $2.30 billion during the quarter, compared to analysts' expectations of $2.20 billion. During the same period last year, the firm posted $1.09 earnings per share. The business's revenue was up 6.1% on a year-over-year basis. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, equities analysts anticipate that Xylem Inc. will post 4.65 earnings per share for the current year.
Xylem Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Thursday, August 28th. Xylem's payout ratio is 41.56%.
Wall Street Analysts Forecast Growth
XYL has been the topic of several analyst reports. JPMorgan Chase & Co. initiated coverage on Xylem in a research note on Friday, May 30th. They issued an "overweight" rating and a $148.00 price objective on the stock. Robert W. Baird dropped their target price on Xylem from $149.00 to $146.00 and set an "outperform" rating on the stock in a report on Wednesday, April 30th. Royal Bank Of Canada increased their target price on Xylem from $143.00 to $147.00 and gave the company an "outperform" rating in a report on Wednesday, April 30th. Wall Street Zen raised Xylem from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. Finally, UBS Group increased their target price on Xylem from $164.00 to $168.00 and gave the company a "buy" rating in a report on Tuesday, August 5th. Six research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $151.57.
Check Out Our Latest Stock Report on Xylem
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Stories

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.